Department of Biomedical Analysis, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, 1432-1 Horinouchi, Hachioji, Tokyo, 192-0392, Japan.
Department of Pharmacy, Hokushin General Hospital, 1-5-63 Nishi, Nakano, Nagano, 383-8505, Japan.
Anal Sci. 2021 Sep 10;37(9):1301-1304. doi: 10.2116/analsci.21N004. Epub 2021 Feb 19.
An in-hospital rapid method for quantifying the serum level of favipiravir (FPV) in the pharmacological treatment of COVID-19 was developed by an appropriate combination of a solid-phase extraction treatment and a reversed-phase HPLC/UV detection system. The quantification method was well-validated and applied to measuring the serum FPV level in a clinical practice at a general hospital that accepts COVID-19 patients. Furthermore, an analysis of data from our preliminary interaction analysis revealed, for the first time, that FPV selectively forms complexes with ferric (Fe) and cupric (Cu) ions.
一种用于在 COVID-19 的药物治疗中定量检测血清中法匹拉韦(FPV)水平的院内快速方法,是通过固相萃取处理和反相 HPLC/UV 检测系统的适当组合开发的。该定量方法经过了充分验证,并应用于一家收治 COVID-19 患者的综合医院的临床实践中测量血清 FPV 水平。此外,我们的初步相互作用分析数据首次表明,FPV 选择性地与三价铁(Fe)和二价铜(Cu)离子形成配合物。